A novel variant in CYFIP2 in a girl with severe disabilities and bilateral perisylvian polymicrogyria




Salokivi Tommi, Parkkola Riitta, Rajendran Yasmin, Bharadwaj Thashi, Acharya Anushree, Leal Suzanne M., Järvelä Irma, Arvio Maria, Schrauwen Isabelle

PublisherWiley

2023

American Journal of Medical Genetics Part A

AMERICAN JOURNAL OF MEDICAL GENETICS PART A

1552-4825

1552-4833

DOIhttps://doi.org/10.1002/ajmg.a.63478

http://dx.doi.org/10.1002%2Fajmg.a.63478

https://research.utu.fi/converis/portal/detail/Publication/182384787



Bilateral perisylvian polymicrogyria (BPP) is a structural malformation of the cerebral cortex that can be caused by several genetic abnormalities. The most common clinical manifestations of BPP include intellectual disability and epilepsy. Cytoplasmic FMRP-interacting protein 2 (CYFIP2) is a protein that interacts with the fragile X mental retardation protein (FMRP). CYFIP2 variants can cause various brain structural abnormalities with the most common clinical manifestations of intellectual disability, epileptic encephalopathy and dysmorphic features. We present a girl with multiple disabilities and BPP caused by a heterozygous, novel, likely pathogenic variant (c.1651G>C: p.(Val551Leu) in the CYFIP2 gene. Our case report broadens the spectrum of genetic diversity associated with BPP by incorporating CYFIP2.


Last updated on 2024-19-12 at 08:50